π¦
|
Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.
10 auth.
M. Joner,
A. Finn,
A. Farb,
E. Mont,
F. Kolodgie,
E. Ladich,
...
R. Kutys,
K. Skorija,
H. Gold,
R. Virmani
|
11 |
2006 |
11 π¦
|
π
|
Pathological Correlates of Late Drug-Eluting Stent Thrombosis: Strut Coverage as a Marker of Endothelialization
8 auth.
A. Finn,
M. Joner,
G. Nakazawa,
F. Kolodgie,
J. Newell,
M. John,
...
H. Gold,
R. Virmani
|
10 |
2007 |
10 π
|
π
|
Drug-Eluting Stent and Coronary Thrombosis: Biological Mechanisms and Clinical Implications
7 auth.
T. LΓΌscher,
J. Steffel,
F. Eberli,
M. Joner,
G. Nakazawa,
F. Tanner,
...
R. Virmani
|
9 |
2007 |
9 π
|
π
|
Vascular Responses to Drug Eluting Stents: Importance of Delayed Healing
7 auth.
A. Finn,
G. Nakazawa,
M. Joner,
F. Kolodgie,
E. Mont,
H. Gold,
...
R. Virmani
|
9 |
2007 |
9 π
|
π¦
|
Endothelial cell recovery between comparator polymer-based drug-eluting stents.
13 auth.
M. Joner,
G. Nakazawa,
A. Finn,
Shawn Chin Quee,
Leslie A. Coleman,
Eduardo Acampado,
P. S. Wilson,
K. Skorija,
Qi Cheng,
Xin Xu,
...
H. Gold,
F. Kolodgie,
R. Virmani
|
9 |
2008 |
9 π¦
|
π
|
Delayed Arterial Healing and Increased Late Stent Thrombosis at Culprit Sites After Drug-Eluting Stent Placement for Acute Myocardial Infarction Patients: An Autopsy Study
10 auth.
G. Nakazawa,
A. Finn,
M. Joner,
E. Ladich,
R. Kutys,
E. Mont,
...
H. Gold,
A. Burke,
F. Kolodgie,
R. Virmani
|
9 |
2008 |
9 π
|
π
|
Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions
26 auth.
L. RΓ€ber,
G. Mintz,
K. Koskinas,
T. Johnson,
N. Holm,
Y. Onuma,
M. Radu,
M. Joner,
Bo Yu,
H. Jia,
N. Meneveau,
J. M. de la Torre Hernandez,
J. Escaned,
J. Hill,
F. Prati,
...
A. Colombo,
C. Di Mario,
E. Regar,
D. Capodanno,
W. Wijns,
R. Byrne,
G. Guagliumi,
F. Alfonso,
R. Bhindi,
Z. Ali,
R. Carter
|
9 |
2018 |
9 π
|
π¬
|
Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas GrΓΌntzig Lecture ESC 2014
R. Byrne,
M. Joner,
A. Kastrati
|
8 |
2015 |
8 π¬
|
π
|
Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis
7 auth.
K. Yahagi,
F. Kolodgie,
F. Otsuka,
A. Finn,
H. Davis,
M. Joner,
...
R. Virmani
|
8 |
2016 |
8 π
|
π¬
|
Has Our Understanding of Calcification in Human Coronary Atherosclerosis Progressed?
F. Otsuka,
K. Sakakura,
K. Yahagi,
M. Joner,
R. Virmani
|
8 |
2014 |
8 π¬
|
π’
|
Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment.
11 auth.
F. Otsuka,
R. Byrne,
K. Yahagi,
Hiroyoshi Mori,
E. Ladich,
David R. Fowler,
...
R. Kutys,
E. Xhepa,
A. Kastrati,
R. Virmani,
M. Joner
|
8 |
2015 |
8 π’
|
π
|
Incidence and predictors of restenosis after coronary stenting in 10β
004 patients with surveillance angiography
10 auth.
S. Cassese,
R. Byrne,
T. Tada,
S. Pinieck,
M. Joner,
T. Ibrahim,
...
Lamin A. King,
M. Fusaro,
K. Laugwitz,
A. Kastrati
|
8 |
2013 |
8 π
|
π’
|
Anatomic assessment of sympathetic peri-arterial renal nerves in man.
9 auth.
K. Sakakura,
E. Ladich,
Qi Cheng,
F. Otsuka,
K. Yahagi,
David R. Fowler,
...
F. Kolodgie,
R. Virmani,
M. Joner
|
8 |
2014 |
8 π’
|